Latest News

Nvidia blows away expectations again, and it still might be just getting started.

Kohl's leads retailers higher today, but beware: The rally won't last.

The patient’s elevated levels of liver enzymes appear to be resolving without hospitalization or medical intervention, the company said.

BoA analysts said trade-induced geopolitical uncertainty would continue to support the metals, with growing concern about the U.S. government’s fiscal situation possibly catalyzing the next leg up.

The lawsuit concerns an interview of former Vice President Kamala Harris in the run-up to the elections on CBS News’ ‘60 Minutes.’

Arista stock fell amid Nvidia's disclosure that it has nabbed Meta Platforms and Google as new customers for Ethernet networking gear in data centers.

The United-JetBlue pact gives United a foothold into JFK while JetBlue gains more access to Newark.

Sekisui’s price rose about 8.7% over the past year from $5.98 to $6.50 as of Tuesday’s closing price.

ARK ETFs' Cathie Wood buys 251,080 shares of Tempus AI, a precision medicine company, amid short seller attack and bullish technical indicators.>ARK ETFs' Cathie Wood buys 251,080 shares of Tempus AI, a precision medicine company, amid short seller attack and bullish technical indicators.ARK ETFs' Cathie Wood buys 251,080 shares of Tempus AI, a precision medicine company, amid short seller attack and bullish technical indicators.

Intellia reports a grade 4 liver enzyme elevation in a Nex-Z trial patient; no hospitalization is required, and enrollment remains on track across programs.

Burlington stock rises as Q1 EPS beats expectations, with the CEO expressing confidence in managing tariff impact and reaffirming FY25 guidance.

ORIC's Phase 1b trial of ORIC-944 in mCRPC shows PSA responses and strong tolerability, with Phase 3 trials and financing plans underway.

The multi-year deal will integrate NYT’s content into Amazon's AI tools, including Alexa, expanding access to journalism and boosting customer experiences across platforms.

Stanley Druckenmiller of the Duquesne Family Office may have just found his next big opportunity in the artificial intelligence (AI) chip market.

Macy's (NYSE: M) reported Q1 results above expectations, but lowered full-year earnings guidance due to tariffs and consumer spending. Exciting earnings season.

Grayscale’s Global Head of ETFs, Dave LaValle, encouraged cryptocurrency skeptics to educate themselves about the “disruptive” potential of the asset class.